Filing Details
- Accession Number:
- 0001209191-17-044704
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-10 19:59:54
- Reporting Period:
- 2017-07-07
- Filing Date:
- 2017-07-10
- Accepted Time:
- 2017-07-10 19:59:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422997 | Petrus Bekker | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-07 | 19,587 | $6.30 | 79,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-07 | 19,587 | $9.30 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-07-10 | 290 | $6.30 | 60,129 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-10 | 290 | $9.30 | 59,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-07 | 19,587 | $0.00 | 19,587 | $6.30 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-07-10 | 290 | $0.00 | 290 | $6.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,164 | 2020-08-10 | No | 4 | M | Direct | |
| 9,874 | 2020-08-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- As of July 7, 2017, and prior to this transaction, the exercised options were fully vested.
- Not applicable.
Billionaire Hedge Funds
